
What Are the 9 Influenza Vaccines Available for the 2025–2026 Respiratory Virus Season?
The 9 influenza vaccines available for the upcoming respiratory virus season come from 4 manufacturers in single-dose syringes and vials and multidose vials may still be available.
Key: IIV, inactivated influenza vaccine (injectable); cc, cell-based (eg, ccIIV); RIV, recombinant hemagglutinin influenza vaccine (injectable); aIIV, adjuvanted inactivated influenza vaccine
The CDC and the
For the 2025–2026 season, all US influenza vaccines are trivalent, covering 2 type A strains and 1 type B strain, according to the CDC. Based on recommendations made during the June meeting of the ACIP, the CDC advises use of
Notable 2025-2026 updates
- FluMist ((influenza vaccine live attenuated, intranasal) may now be
self-administered or given by a caregiver . The ACIP made its recommendation in April 2025 and the product is anticipated to be available for the 2025-2026 flu season. - Flublok (recombinant influenza vaccine) was approved i March 2025 for individuals aged 9 years and older, expanding eligibility from previous age limit of 18 years or older. The information has been updated in the Table of available US influenza vaccines for the 2025-2026 season.
There are no preferential recommendations made between vaccine types for most individuals. For adults aged 65 years and older, however, the preferred influenza vaccines are high-dose, inactivated, recombinant or adjuvanted inactivated formulations whenever they are available.
Pediatric Dosing. Children aged 6 months to 8 years who are receiving influenza vaccine for the first time (or with unknown prior vaccination history) should be given 2 doses at least 4 weeks apart.
The short slide show above is a quick look at the 9 influenza vaccine products available for the upcoming respiratory virus season, adapted from a popular
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.